반응형
Global Data Intelligence Center 
구분 보고서 (영문) 업로드 날짜
제약/바이오/
임상시험
Slow Progress for Female Contraceptive Trials 08-30-2023
Samsung Bioepis and Organon’s SB5 Displays Promise in Humira Biosimilar Study 08-31-2023
Eli Lilly Gearing Up to Infiltrate the Anti-Obesity Market as Phase III Trial for Retatrutide Begins 08-31-2023
Contract Manufacturing: Opportunities and Threats – August 2023 08-31-2023
Depression Clinical Trials During and After the COVID-19 Pandemic 08-31-2023
Highly anticipated first 10 drugs released for Medicare price negotiation could see minimal commercial impact 09-01-2023
Exelixis’s Cabometyx Phase III Trial Results Spark Hope for Patients with Pancreatic NETs 09-01-2023
질환별 IgA Nephropathy (Berger's Disease): Competitive Landscape 08-29-2023
Record Number of Respiratory Syncytial Virus (RSV) Designations Awarded in 2022 08-30-2023
Idiopathic Hypersomnia: Competitive Landscape 08-31-2023
A Market Leader Shuffle Is Expected in the Crohn’s Disease Space 08-31-2023
Diabetic Nephropathy: Competitive Landscape 09-01-2023
Leading Players in Decompensated Cirrhosis Due to NASH 09-05-2023
Oral Contraceptive Pills Found to Increase the Risk of Mood Disorders in Women 09-05-2023
Major Unmet Needs Plague Classification and Treatment of Myasthenia Gravis Patients 09-06-2023
컨퍼런스/심포지엄/학회 VTE Risk Elevated in Swedish Patients Hospitalized for COVID-19 09-05-2023
Direct Oral Anticoagulants’ Positive Effects on Cancer-Associated VTE 09-05-2023
Myosin Inhibitors’ Central Role in the Future of Hypertrophic Cardiomyopathy 09-05-2023
New 2023 Guidelines for the Management of Cardiomyopathies 09-05-2023

반응형

+ Recent posts